|
Gavin Hilary James Wood
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 0.01 per share. |
02 Sep 2025 |
96,000 |
0
(0%)
|
0%
|
0.0 |
950
|
Ordinary Shares with a nominal value of GBP0.001 per share |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.01 per share. |
28 Aug 2025 |
207,000 |
986,352
(0%)
|
0%
|
0.0 |
2,091
|
Ordinary Shares with a nominal value of GBP0.001 per share |
|
Ali Behbahani
|
Director |
Sale of securities on an exchange or to another person at price $ 0.01 per share. |
15 Aug 2025 |
14,671,794 |
0
(0%)
|
2%
|
0.0 |
176,062
|
Ordinary Shares with a nominal value of 0.001 GBP per share |
|
Ali Behbahani
|
Director |
Sale of securities on an exchange or to another person at price $ 0.01 per share. |
15 Aug 2025 |
4,828,206 |
14,671,794
(2%)
|
0%
|
0.0 |
53,110
|
Ordinary Shares with a nominal value of 0.001 GBP per share |
|
Elliot Norry
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,074,696 |
1,074,696
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,612,032 |
1,612,032
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,074,696 |
1,074,696
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
5,143,248 |
5,143,248
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
3,428,832 |
3,428,832
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,612,032 |
1,612,032
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,074,696 |
1,074,696
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,612,032 |
1,612,032
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Joanna Brewer
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,074,696 |
1,074,696
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Joanna Brewer
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,612,032 |
1,612,032
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Cintia Piccina
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,612,032 |
1,612,032
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Cintia Piccina
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Feb 2025 |
1,074,696 |
1,074,696
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
17 Jan 2025 |
5,584 |
7,510
(0%)
|
0%
|
0.6 |
3,243
|
American Depositary Shares representing Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
17 Jan 2025 |
30,601 |
44,327
(0%)
|
0%
|
0.6 |
17,773
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
17 Jan 2025 |
5,584 |
7,510
(0%)
|
0%
|
0.6 |
3,243
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
17 Jan 2025 |
5,584 |
7,510
(0%)
|
0%
|
0.6 |
3,243
|
American Depositary Shares representing Ordinary Shares |
|
Cintia Piccina
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 0.57 per share. |
15 Jan 2025 |
12,991 |
18,421
(0%)
|
0%
|
0.6 |
7,467
|
American Depositary Shares representing Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.57 per share. |
13 Jan 2025 |
29,096 |
41,582
(0%)
|
0%
|
0.6 |
16,724
|
American Depositary Shares representing Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.57 per share. |
13 Jan 2025 |
9,803 |
13,756
(0%)
|
0%
|
0.6 |
5,635
|
American Depositary Shares representing Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.59 per share. |
13 Jan 2025 |
4,268 |
5,845
(0%)
|
0%
|
0.6 |
2,509
|
American Depositary Shares representing Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.59 per share. |
13 Jan 2025 |
5,471 |
7,623
(0%)
|
0%
|
0.6 |
3,216
|
American Depositary Shares representing Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.59 per share. |
13 Jan 2025 |
12,539 |
17,801
(0%)
|
0%
|
0.6 |
7,372
|
American Depositary Shares representing Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.59 per share. |
13 Jan 2025 |
17,934 |
25,711
(0%)
|
0%
|
0.6 |
10,543
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
Sale of securities on an exchange or to another person at price $ 0.59 per share. |
13 Jan 2025 |
5,471 |
7,623
(0%)
|
0%
|
0.6 |
3,216
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
Sale of securities on an exchange or to another person at price $ 0.57 per share. |
13 Jan 2025 |
9,803 |
13,756
(0%)
|
0%
|
0.6 |
5,635
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
Sale of securities on an exchange or to another person at price $ 0.59 per share. |
13 Jan 2025 |
4,268 |
5,845
(0%)
|
0%
|
0.6 |
2,509
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 0.59 per share. |
13 Jan 2025 |
8,124 |
11,516
(0%)
|
0%
|
0.6 |
4,776
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 0.59 per share. |
13 Jan 2025 |
4,268 |
5,845
(0%)
|
0%
|
0.6 |
2,509
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 0.57 per share. |
13 Jan 2025 |
9,803 |
13,756
(0%)
|
0%
|
0.6 |
5,635
|
American Depositary Shares representing Ordinary Shares |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
660,000 |
660,000
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Priti Hegde
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
1,144,686 |
1,144,686
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
John P. Furey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
660,000 |
660,000
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Ali Behbahani
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
1,144,686 |
1,144,686
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Garry E. Menzel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
1,121,604 |
1,121,604
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
1,213,926 |
1,213,926
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
1,583,214 |
1,583,214
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Andrew R. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
660,000 |
660,000
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Cintia Piccina
|
Chief Commercial Officer |
|
18 Jun 2024 |
24,531 |
38,293
(0%)
|
0%
|
0.9 |
22,814
|
American Depositary Shares representing Ordinary Shares |
|
Cintia Piccina
|
Chief Commercial Officer |
|
18 Mar 2024 |
5,088,864 |
5,088,864
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Cintia Piccina
|
Chief Commercial Officer |
|
18 Mar 2024 |
1,130,832 |
1,130,832
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.67 per share. |
16 Jan 2024 |
30,080 |
44,848
(0%)
|
0%
|
0.7 |
20,244
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
|
16 Jan 2024 |
12,967 |
19,257
(0%)
|
0%
|
0.7 |
8,727
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
|
16 Jan 2024 |
5,309 |
7,785
(0%)
|
0%
|
0.7 |
3,573
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
|
16 Jan 2024 |
2,287 |
3,363
(0%)
|
0%
|
0.8 |
1,807
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
|
16 Jan 2024 |
5,309 |
7,785
(0%)
|
0%
|
0.7 |
3,573
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
|
16 Jan 2024 |
12,805 |
19,015
(0%)
|
0%
|
0.7 |
8,618
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
|
16 Jan 2024 |
4,681 |
7,023
(0%)
|
0%
|
0.8 |
3,698
|
American Depositary Shares representing Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.79 per share. |
16 Jan 2024 |
9,304 |
14,104
(0%)
|
0%
|
0.8 |
7,350
|
American Depositary Shares representing Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.79 per share. |
16 Jan 2024 |
4,681 |
7,023
(0%)
|
0%
|
0.8 |
3,698
|
American Depositary Shares representing Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.67 per share. |
16 Jan 2024 |
13,599 |
20,201
(0%)
|
0%
|
0.7 |
9,152
|
American Depositary Shares representing Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.67 per share. |
16 Jan 2024 |
5,309 |
7,785
(0%)
|
0%
|
0.7 |
3,573
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
|
15 Jan 2024 |
565,416 |
565,416
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Joanna Brewer
|
Chief Scientific Officer |
|
15 Jan 2024 |
2,544,432 |
2,544,432
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2024 |
81,906 |
81,906
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2024 |
565,416 |
565,416
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2024 |
2,544,432 |
2,544,432
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2024 |
1,696,272 |
1,696,272
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Joanna Brewer
|
Chief Scientific Officer |
|
15 Jan 2024 |
565,416 |
565,416
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
|
15 Jan 2024 |
2,544,432 |
2,544,432
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
|
15 Jan 2024 |
565,416 |
565,416
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
|
15 Jan 2024 |
2,544,432 |
2,544,432
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Helen Tayton-Martin
|
Chief Business & Strgy Officer |
|
15 Jan 2024 |
565,416 |
565,416
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Helen Tayton-Martin
|
Chief Business & Strgy Officer |
|
15 Jan 2024 |
2,544,432 |
2,544,432
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Ali Behbahani
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2024 |
40,950 |
40,950
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Gavin Hilary James Wood
|
Chief Financial Officer |
|
15 Jan 2024 |
565,416 |
565,416
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Gavin Hilary James Wood
|
Chief Financial Officer |
|
15 Jan 2024 |
2,544,432 |
2,544,432
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2024 |
7,633,296 |
7,633,296
|
-
|
|
-
|
Option to purchase Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.84 per share. |
11 Jan 2024 |
11,945 |
18,395
(0%)
|
0%
|
0.8 |
9,994
|
American Depositary Shares representing Ordinary Shares |
|
Adrian Rawcliffe
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.85 per share. |
11 Jan 2024 |
17,257 |
26,388
(0%)
|
0%
|
0.9 |
14,739
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
|
11 Jan 2024 |
5,220 |
7,874
(0%)
|
0%
|
0.9 |
4,458
|
American Depositary Shares representing Ordinary Shares |
|
John Lunger
|
Chief Patient Supply Officer |
|
11 Jan 2024 |
4,009 |
6,104
(0%)
|
0%
|
0.8 |
3,354
|
American Depositary Shares representing Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.84 per share. |
11 Jan 2024 |
4,009 |
6,104
(0%)
|
0%
|
0.8 |
3,354
|
American Depositary Shares representing Ordinary Shares |
|
William C. Bertrand
|
Chief Operating Officer |
Sale of securities on an exchange or to another person at price $ 0.85 per share. |
11 Jan 2024 |
5,220 |
7,874
(0%)
|
0%
|
0.9 |
4,458
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
|
11 Jan 2024 |
4,009 |
6,104
(0%)
|
0%
|
0.8 |
3,354
|
American Depositary Shares representing Ordinary Shares |
|
Elliot Norry
|
Chief Medical Officer |
|
11 Jan 2024 |
7,799 |
11,841
(0%)
|
0%
|
0.9 |
6,661
|
American Depositary Shares representing Ordinary Shares |